You have no items in your shopping cart.
" inertia="description">
You have no items in your shopping cart.
Catalog Number | orb1141090 |
---|---|
Category | Antibodies |
Description | <p>Ensituximab (NPC-1C) is a chimeric monoclonal antibody under development for as a candidate for treatment of cancers. The target of the antibody is uncertain and is described as "human colorectal and pancreatic carcinoma-associated antigens", a set of tumor antigens isolated from human cancers. The target might be Mucin 5AC.</p> |
Tested applications | ELISA, FC, Functional Studies, ICC, IF, IP, NeA |
Isotype | IgG1 Kappa |
Concentration | 1mg/ml |
Purity | ≥95% |
Conjugation | Unconjugated |
Alternative names | NOE-102, NPC-1C Read more... |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Recombinant | |
Unconjugated |
Filter by Rating